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Abstract
Background: Antiretroviral therapy has an impressive clinical effect on the human immunodeficiency virus
although its effectiveness depends mainly on the adherence of patients to the therapy. Therefore, this study aimed
to assess adherence status and associated factors of antiretroviral therapy among HIV infected adults on ART at the
University of Gondar Referral Hospital, northwest Ethiopia.
Methods: An institutional based cross-sectional study was conducted from May to June 2015. The systematic
random sampling technique was used to select 440 study participants. Data collected using an
intervieweradministered questionnaire was entered using EPI Info version 7 and analyzed using SPSS version
20. Both bivariate and multivariate logistic regression analyses were done. In the multivariate analysis, variables
with P-value ≤ 0.05 were considered statistically significant between independent variables and the outcome
variable (medication adherence). Adjusted odds ratio (AOR) with a 95% confidence interval was used to
determine the strength and direction of the association.
Results: A total of 440 participants were included in the study. The mean age of participants was 36.09
(SD ± 8.09) years. The overall rate of adherence to ART was 88.2% (95% CI = 85.2, 91.1). Urban residence
(AOR = 6.99, 95% CI: 2.30, 21.27), no co-morbidity (AOR = 0.13, 95% CI: 0.05, 0.33), knowledge about HIV
and ART (AOR = 7.54, 95% CI: 2.69, 21.15), and disclosed HIV status to partners (AOR = 3.65 (1.06, 12.61)
and CD4 count of ≥ 500mm3 (AOR = 3.91, 95% CI: 1.19, 12.81) were significantly associated with adherence.
Conclusion: In this study, the rate of adherence to antiretroviral therapy was low compared to WHO
standard.. Prevention of co-morbidities, improving knowledge through health education, providing strong
drug adherence counseling with more emphasis on the rural community, and encouraging HIV positive
individuals to disclose their HIV status are crucial for ART adherence.
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Background
HIV/AIDS, with which 36.7 million people were living
and 2.1 million newly infected at the end of 2016,
has been one of the major health problems globally.
From the beginning of the epidemic to 2016, 35 mil-
lion people died from AIDS-related illnesses [1–3].
Although the burden of HIV continues to vary signifi-
cantly across countries, Sub-Saharan Africa remains
the most affected with almost 1 in every 25 adults
(4.4%) living with it, accounting for nearly 70% of the
global burden [2]. According to the 2014 estimate the
national HIV prevalence in Ethiopia was 1.14%, and
the number of people living with HIV is 769, 600
with 15, 700 new HIV infections and 35, 600
AIDS-related deaths each year [4].
The Human Immunodeficiency Virus (HIV) infection
does not only upset the health of individuals but also
impacts on households, communities, and the develop-
ment of nations. When countries are affected by HIV,
they also suffer from other infectious diseases, food inse-
curity, and other serious problems [5]. Antiretroviral
therapy has an impressive clinical effect in that it de-
creases the viral replication and viral load which in turn
preserves the CD4 level, decreases the progress of AIDS,
and reduces AIDS-related deaths [6].
However, the clinical outcomes of ART depend
mainly on the adherence of patients to antiretroviral
therapy. Studies show that adherence to antiretroviral
therapy is essential to reduce the multiplication of the
virus and improve disease outcomes [7, 8]. they fur-
ther demonstrate that medication adherence is second
to CD4 count for precisely anticipating progression to
AIDS and death [9, 10]. All round efforts such as
increasing accessibility of HIV screening, counseling,
and ART services by private, government and
non-government organizations have been made to re-
duce morbidity and maintain the quality of life of
HIV-positive individuals [11]. Studies indicate that >
95% adherence to therapeutic schemes is required for
an HIV infected patient to reach full viral suppression
[12–15]. However, adherence to therapeutic regimens
might be difficult for many reasons. For example, the
side effects of HIV medicines could pose challenges
on strict adherence. Besides, the medication dosing
schedule might not fully the patient’s daily activities
[16, 17].
Poor -adherence to highly active antiretroviral therapy
(HAART) diminishes the effectiveness of ART and accel-
erates viral dissemination and drug resistance [18, 19].
This catastrophic event affects patients by reducing their
quality of life and the community as well as the health
system by increasing medical costs.
There has been a considerable progress of access to
ART and HIV counseling and testing in Ethiopia [20].
There are however only a few studies on the adherence
status of ART and its determinant factors in various
parts of the country. The level of adherence is highly af-
fected by the level of commitment of ART service pro-
viders in providing “drug adherence counselling
services”. Since this specialized hospital is providing ser-
vices to more than 5 million people and over five thou-
sand ART users in Amhara Region, knowing the level of
ART adherence and its determinants is essential for
making appropriate interventions.
Therefore, this study aimed to assess adherence status
and associated factors of ART among HIV infected adult
patients on ART at the University of Gondar Referral
Hospital, northwest Ethiopia.
Methods
Study design and setting
An institution based cross-sectional study was con-
ducted from May to June 2015 at the University of Gon-
dar Referral Hospital Chronic HIV Care and Treatment
Clinic. The hospital is found in Gondar town, 727 km
from Addis Ababa, the capital of Ethiopia. This teaching
hospital serves for more than five million people in the
zone and nearby districts and started free ART service in
2006. Currently, it has four outpatient, one ART drug
refill and pre ART follow up, one voluntary testing and
counseling rooms, a pharmacy and a laboratory. More
than 7500 adults and 700 pediatric patients were en-
rolled in the HIV care centre after the hospital started
the care. More than 5100 of the adults were on ART at
the movement. In Ethiopia, the first- line ART regimen is
(TDF+ 3TC+EFV), while AZT+ 3TC+EFV, AZT+ 3TC+
NVP, and TDF+ 3TC+NVP are used as an alternative. The
second line regimen is TDF + 3TC + LPV/r or ATV/r
and AZT + 3TC + LPV/r or ATV/r, whereas AZT +
TDF + 3TC + (ATV/r or LPV/r) is given to patients
with HBV co-infection.
Source/study participants
All HIV infected adults aged ≥18 years e attending care
and treatment the ART Clinic at the University of Gon-
dar Referral Hospital were the study population. How-
ever, patients who had a hearing problem and known
mental disorder were excluded.
Sample size determination and sampling procedure
The sample size was calculated using the single popu-
lation proportion formula (n = [(Zα/2)2 × P (1-P)]/D2)
with the assumption of a 95% level of confidence,
3.5% margin of error, 85% rate of adherence to ART
detected in Harar and Dire Dawa, eastern Ethiopia
[21], and a 10% nonresponse rate which yielded 440.
Participants were selected using the systematic
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random sampling technique, and every 12 patients
were interviewed based on their order of arrival.
Data collection tool and procedure
A structured interviewer-administered questionnaire
was used to collect data. The questions on the explana-
tory variables were prepared using the WHO concep-
tual model and by reviewing international literature.
Pill count is cost effective, simple, and more accurate
than other methods [22]. However, the number of pills
left does not necessarily reflect a consistent use of the
drugs. Therefore, adherence status was assessed based
on the number of pills reported to have been actually
taken one month prior to the data collection period di-
vided by the number of prescribed pills multiplied by
100%. Patients who reported an intake of ≥95% of the
prescribed medication were considered adherent; those
with a reported intake of < 95% were classified as
non-adherent.
The questionnaire was first prepared in English and
translated to Amharic, the local language, and then
retranslated to English to ensure the consistency of
the tool. The pre-test was done on 26 HIV infected
patients on ART at nearby hospital, and modifications
were made based on the findings. One MSc and four
BSc degree graduate nurses who were working out of
the ART clinic were recruited for supervision and data
collection, respectively, after they were trained for two
days. The investigators and the supervisor monitored
the data collection throughout the process.
Operational definition
Knowledgeable
Those respondents who scored points at mean and
above for the knowledge question prepared on HIV and
its treatment otherwise not.
Comorbidity
The presence of any of the chronic disease along with
HIV/AIDs.
Data processing and analysis
Each item of the questionnaire was checked for com-
pleteness and coded manually before data entry. The
data were entered using Epi info version 7 and
exported to SPSS version 20 for data analysis. De-
scriptive statistics, including frequencies, means and
standard deviations were used to describe the data.
Bivariate logistic regression analysis was carried out
and variables with P-values of ≤ 0.2 were entered into
the multivariate logistic regression for final analysis.
Hosmer and Lemeshow fitness of Good test was com-
puted. And adjusted odds ratio with a 95% Confi-
dence interval (CI) was computed to see the presence
Table 1 Socio-demographic characteristic of HIV positive adults
attending care and treatment in University of Gondar Referral
Hospital, Northwest Ethiopia, 2015 (n = 440)
Variable Frequency Percent (%)
Sex
Male 176 40.0
Female 264 60.0
Age
18–28 77 17.5
29–38 212 48.2
39–48 119 27.0
> =49 32 7.3
Marital status
Single 66 15.0
Married 236 53.6
Divorced 69 15.7
Widowed 69 15.7
Religion
Orthodox 378 85.9
Protestant 15 3.4
Muslim 47 10.7
Ethnicity
Amhara 375 85.2
Tigrie 25 5.7
Kimant 40 9.1
Residence
Urban 377 85.7
Rural 63 14.3
Educational status
No formal education 106 24.1
Primary school 83 18.9
Secondary school 210 47.7
College/University 41 9.3
Occupational status
Government employee 87 19.8
Private employee 75 17
Housewife 93 21.1
Merchant 86 19.5
Farmer 33 7.5
Daily laborer 26 5.9
Others a 40 9.1
Income b
< 1000 118 26.8
1000–2000 127 28.9
2001–3000 85 19.3
> 3000 110 25
astudent, garden
bIn Ethiopian Birr
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of strength and the direction of association between
dependent and independent variables.
Result
Socio-demographic characteristics of participants
A total of 440 participants were interviewed with a 100%
response rate. The mean age of participants was 36.09
(SD ± 8.09) years. More than half, 264 (60%), of the par-
ticipants were females, 378 (85.9%) Orthodox Christians
and 375 (85.2%) Amhara by ethnicity. The majority, 377
(85.7%), and a quarter, 106 (24.1%), of the participants
were urban dwellers and had no formal education, re-
spectively (Table 1).
Clinical characteristics of participants
Of the participants, 297 (67.5%) were knowledgeable
about HIV/AIDS and its treatments; more than half, 240
(54.5%) knew about the HIV status of their partners, and
200 (45.5%) of the partners were seropositive; the CD4
count of 266 (60.5%) was < 500 mm3 (Table 2).
The overall level of adherence to antiretroviral therapy
In this study, the rate of adherence to antiretroviral ther-
apy was 88.2% (95% CI = 85.2, 91.1). The rate is higher
(92.0%) among urban and lower (65.1%) among rural
residents.
Factors associated with adherence to antiretroviral
therapy
The multivariate logistic regression analysis showed
that urban residence, absence of co-morbidity, know-
ledge about HIV/AIDS, and ART, disclosing HIV sta-
tus to partner and recent CD4 count ≥ 500 mm3
were significantly associated with adherence to anti-
retroviral therapy.
Thus, HIV infected patients who lived in urban settings
were 7 times (AOR= 6.99, 95% CI: 2.30, 21.27) more likely
to adhere to their antiretroviral therapy (ART) than rural
residents. Participants without co-morbidity were 87%
(AOR= 0.13; 95% CI: (0.05, 0.33) less likely to adhere than
participants with co-morbidity. Furthermore, participants
who were knowledgeable about HIV and antiretroviral ther-
apy were 7.5 times (AOR= 7.54 95% CI: 2.69, 21.15) more
likely to be adherent compared with non-knowledgeable
Table 2 Clinical characteristics and antiretroviral therapy
condition of the study participants, University of Gondar Referral
Hospital, Northwest Ethiopia, 2015 (n = 440)
Variables Frequency Percent
Comorbidities
Yes 117 26.6
No 323 73.4
Knowledge about treatment
Knowledgeable 297 67.5
Not knowledgeable 143 32.5
Knowing HIV status of partners
Yes 240 54.5
No 200 45.5
HIV status of the partner (n = 240)
Positive 200 83.3
Negative 40 16.7
Family disclosure status
Yes 321 73.0
No 119 27.0
CD4 count
< 500 mm3 266 60.5
> = 500 mm3 174 39.5
Substance use in the past 1 year
Yes 29 6.6
No 411 93.4
Partner in the past 1 year
Yes 314 71.4
No 126 28.6
Length of stay with a current partner (n = 314)
< 1 year 67 21.3
1–4 year 39 12.4
4 year 208 66.3
Number of partners (n = 314)
One 268 85.4
More than one 46 14.6
Discussion about safe sex (n = 314)
Yes 256 81.5
No 58 18.5
Duration since tested HIV positive
< 1 year 30 6.8
1–5 year 172 39.1
5–10 year 231 52.5
> 10 years 7 1.6
Table 2 Clinical characteristics and antiretroviral therapy
condition of the study participants, University of Gondar Referral
Hospital, Northwest Ethiopia, 2015 (n = 440) (Continued)
Variables Frequency Percent
Duration since on ART
< 1 year 62 14.1
1–5 years 377 85.7
> 5 years 1 0.2
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Table 3 Bivariate and multivariate analysis for adherence to antiretroviral therapy among HIV positive adults attending care and
treatment in University of Gondar Referral Hospital, Northwest Ethiopia, 2015 (n = 440)
Variables Adherence Status COR (95% CI) AOR (95% CI)
Adherent Non Adherent
Sex
Male 153 23 1
Female 235 29 1.22(0.68,2.18)
Age (in year)
18–28 66 11 1.11(0.35,3.50)
29–38 191 21 1.1.68(0.59,4.84)
39–48 104 15 1.28(0.43,3.85)
> = 49 27 5 1
Marital status
Single 54 12 0.76(0.31,1.91)
Married 213 23 1.57(0.71,3.48)
Divorced 62 7 1.50(0.54,4.20)
Widowed 59 10 1
Educational status
No formal education 97 9 1.17(0.34,4.02)
Primary school 75 8 1.01(0.29,3.58)
Secondary school 79 31 0.62(0.21,1.88)
College/University 36 5 1
Occupation
Government employee 79 8 3.75(0.97,10.24)
Private employee 70 5 5.31(0.89,16.64)
Housewife 85 8 4.03(0.87,10.99)
Merchant 74 12 2.34(0.93,5.89)
Farmer 27 6 1.71(0.55,5.25)
Daily laborer 20 6 4.55(0.92,22.56)
Others 29 11 1
Residence
Urban 347 30 6.21(3.28,11.75)a 6.99(2.30,21.26) b
Rural 41 22 1 1
Incomec
< 1000 92 26 0.28(0.12,0.64)a 0.42(0.12,1.52)
1000–2000 116 11 0.83(0.32, 2.14) 0.95(0.24,3.69)
2001–3000 78 7 0.87(0.30,2.51) 1.09(0.27,4.41)
> 3000 102 8 1 1
Comorbidities
Yes 82 35 0.13(0.07, 0.24)a 0.13(0.05, 0.33)b
No 306 17 1 1
Knowledge about treatment
Knowledgeable 282 15 6.56(3.46,12.45)a 7.54(2.69,21.15)b
Not Knowledgeable 106 37 1 1
Knowing HIV status of partners
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patients. In addition, participants who disclosed their HIV
status to their partners were 3.7 times (AOR= 3.65 (1.06,
12.61)) as likely to be adherent as those who did not dis-
close. The odds of ART adherence was found high among
participants with a CD4 count of ≥ 500mm3 (AOR= 3.91
95% CI: 1.19, 12.81)) (Table 3).
Discussion
In this study, the rate of adherence to antiretroviral
therapy was found to be 88.2% (95% CI = 85.2, 91.1).
This is almost in-line with those of studies done at
Dessie referral hospital [3], Debre Markos referral
hospital [7], Eastern Ethiopia [5], and Global Hospital
[10], and Nepal [6], which reported 90, 88.6, 85%,
and, 90.8, and 85.5%, respectively.
However, it is higher than there of studies done in
Savannakhet and Sethathirath hospitals (60%) [4], Dubti
hospital (81.1%) [11], Myanmar (76.24%) [12], China
(81.8%) [13], and a Tertiary care hospital in Aurangabad
(78%) [1]. This difference might be due to differences in
socio-demographic characteristic, sample size large in
this study, and difference in study designs.
This finding is lower than that of another study
conducted in Debre Birhan referral hospital and
health center (95.5%) [9]. The variation might be due
to differences in study settings and socio-demographic
characteristics.
In the current study, associations were observed be-
tween adherence to ART and different variables.
Urban residence had a significant association with
good adherence. The possible justification could be
Table 3 Bivariate and multivariate analysis for adherence to antiretroviral therapy among HIV positive adults attending care and
treatment in University of Gondar Referral Hospital, Northwest Ethiopia, 2015 (n = 440) (Continued)
Variables Adherence Status COR (95% CI) AOR (95% CI)
Adherent Non Adherent
Yes 220 20 0.33(0.16,0.68)a 0.57(0.64,4.96)
No 58 16 1 1
HIV status of partners
Negative 35 5 0.57(0.19,1.66) 0.91 (0.21, 4.01)
Positive 185 15 1 1
Discuss about safe sex with a partner
Yes 232 24 0.4(0.19,0.85)a 0.83(0.18,3.88)
No 46 12 1 1
Disclosing HIV status of partners
Yes 369 42 4.62(2.02,10.60)a 3.65(1.06,12.61)b
No 19 10 1 1
Recent CD4 count
< 500 mm3 227 39 1 1
> =500 mm3 161 13 2.13(1.1,4.11)a 3.91(1.19,12.81)b
Number of partner
1 240 28 1.81(0.77,4.25) 1.01(0.21,4.73)
> 1 38 8 1 1
Length of stay with current partner
< 1 year 56 11 0.45(0.20,1.02 2.9(0.47,17.97)
1–4 years 31 8 0.35(0.14,0.87)a 0.76(0.19,3.14)
> 4 years 191 17 1 1
Duration since tested HIV positive
< 1 year 24 6 0.67(0.07,6.64)
1–5 year 154 18 1.43(0.16,12.52)
5–10 year 204 27 1.26(0.15,10.86)
> 10 years 6 1 1
aSignificant variables in bivariate analysis,
bSignificant variables in multivariate analysis,
cIn Ethiopian Birr
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that in this study urban residents were more edu-
cated. This might increase their awareness and access
to HIV therapy. The presence of co-morbidity had a
significant association with the outcome variable. In
the study, participants without co-morbidity had good
adherence to antiretroviral therapy, like a similar
study reported elsewhere [5]. The possible explanation
might be that when patients had co-morbidities, they
might have pill burden. As a result, they might miss
ART medications as they give more attention to the
acute problem.
Being knowledgeable about HIV and antiretroviral
therapy had a significant association with good adher-
ence. This is similar to the results of studies done in
Nepal [6] and China [13]. Disclosure of status of HIV to
family/partner also had a significant association with
good adherence. This agreed to the findings of studies
done in Dessie referral hospital, eastern Ethiopia,
Felege-Hiwot and Gondar University hospitals [3, 5, 8]
and Nepal [6].
Recent CD4 count was significantly higher among pa-
tients with good ART adherence. This is similar to the
findings of a study done in HIV Epidemiology Research
(HER) in the US [2].
In this study, adherence was assessed according to
data actually taken during the previous one month.
So, the participants might be subjected to recall bias.
Since the data was collected using an interviewer
administered technique, it might also be exposed to
social desirability bias. However, the participants were
adequately informed about the relevance of the study
and the importance of genuineness. Additionally, the
data collectors were professionals working out of the
ART clinics. Patients attending health centers were
not included in this study. This might impose a limi-
tation on the generalization of the findings to all
ART users in the region.
Conclusion
In this study, antiretroviral therapy adherence was found
low compared to the WHO standard. Urban residence,
no co-morbidity, being knowledgeable about HIV and its
treatment, disclosing HIV status to partners and CD4
count ≥ 500 mm3 were factors significantly associated
with good ART adherence. High CD4 count was found
to be a proxy indicator of good ART adherence. Thus,
prevention of co-morbidities, improving knowledge
through health education, providing strong drug adher-
ence counseling with more emphasis on the rural com-
munity, and encouraging HIV positive individuals to
disclose their HIV status are crucial for ART adherence.
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